Vicky Carlisle summarises a promising recent RCT on the efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy.[read the full story...]
Douglas Levinson on a genome-wide meta-analysis of depression in 807,553 individuals, which identifies 102 independent variants relating to the genetics of depression.[read the full story...]
Thalia Eley and Gerome Breen explore a new systematic meta-review of predictors of antidepressant treatment outcome in depression, which looks at clinical and demographic variables, but also biomarkers including both genetic and neuroimaging data.[read the full story...]
Ioana Cristea highlights some of the key ideas from the recently published Lancet Psychiatry Commission on psychological treatments research in tomorrow’s science. She also raises a number of objections to the 50-page report, which we hope will generate some much needed discussion on this topic.
Look out for our #SeeingFurther podcast with the authors of the Commission and a Twitter chat at 12:30pm GMT on Monday 19th March.[read the full story...]
Alison Turner summarises a new digital report from the King’s Fund, which features a range of case studies highlighting how innovations have improved patient care and experience.[read the full story...]
One of the criticisms that health professionals sometimes make of evidence-based research is that individual studies or reviews do not apply to the specific patient they are caring for. Of course, each patient is unique with their own values and preferences, as well as their own particular clinical characteristics, genetic make-up, biological markers and sociodemographic [read the full story…]